# Pattern Group Inc.: financial statements, quarterly

PTRN · Nasdaq · CIK 1811935 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ptrn.md) · [Financials](/companies/ptrn/financials.md) · [Filings](/companies/ptrn/filings.md) · [Insiders](/companies/ptrn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ptrn/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [439](/filings/0001811935-25-000057.md) | [515 d](/filings/0001811935-26-000013.md) | [540](/filings/0001811935-26-000039.md) | [598](/filings/0001811935-26-000054.md) | [640](/filings/0001811935-25-000057.md) | [723 d](/filings/0001811935-26-000013.md) | [774](/filings/0001811935-26-000039.md) | [877](/filings/0001811935-26-000054.md) |
| Cost of revenue | $m | not reported | not reported | [249](/filings/0001811935-25-000057.md) | [295 d](/filings/0001811935-26-000013.md) | [305](/filings/0001811935-26-000039.md) | [341](/filings/0001811935-26-000054.md) | [356](/filings/0001811935-25-000057.md) | [409 d](/filings/0001811935-26-000013.md) | [433](/filings/0001811935-26-000039.md) | [492](/filings/0001811935-26-000054.md) |
| Research and development | $m | not reported | not reported | [4.1](/filings/0001811935-25-000057.md) | [5.3 d](/filings/0001811935-26-000013.md) | [5.6](/filings/0001811935-26-000039.md) | [6.5](/filings/0001811935-26-000054.md) | [24.6](/filings/0001811935-25-000057.md) | [9.6 d](/filings/0001811935-26-000013.md) | [11.2](/filings/0001811935-26-000039.md) | [13.0](/filings/0001811935-26-000054.md) |
| Operating income | $m | not reported | not reported | [17.7](/filings/0001811935-25-000057.md) | [23.1 d](/filings/0001811935-26-000013.md) | [29.4](/filings/0001811935-26-000039.md) | [30.1](/filings/0001811935-26-000054.md) | [(60.2)](/filings/0001811935-25-000057.md) | [26.0 d](/filings/0001811935-26-000013.md) | [39.6](/filings/0001811935-26-000039.md) | [35.5](/filings/0001811935-26-000054.md) |
| Income tax | $m | not reported | not reported | [5.2](/filings/0001811935-25-000057.md) | [6.0 d](/filings/0001811935-26-000013.md) | [8.0](/filings/0001811935-26-000039.md) | [8.1](/filings/0001811935-26-000054.md) | [(32.2)](/filings/0001811935-25-000057.md) | [(0.8) d](/filings/0001811935-26-000013.md) | [12.3](/filings/0001811935-26-000039.md) | [10.0](/filings/0001811935-26-000054.md) |
| Net income | $m | [17.7](/filings/0001811935-25-000057.md) | [17.8](/filings/0001811935-25-000057.md) | [14.2](/filings/0001811935-25-000057.md) | [18.2 d](/filings/0001811935-26-000013.md) | [22.8](/filings/0001811935-26-000054.md) | [23.8](/filings/0001811935-26-000054.md) | [(59.1)](/filings/0001811935-25-000057.md) | [28.7 d](/filings/0001811935-26-000013.md) | [29.2](/filings/0001811935-26-000054.md) | [27.5](/filings/0001811935-26-000054.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.09](/filings/0001811935-25-000057.md) | not reported | [0.17](/filings/0001811935-26-000039.md) | [0.18](/filings/0001811935-26-000054.md) | [(2.19)](/filings/0001811935-25-000057.md) | not reported | [0.16](/filings/0001811935-26-000039.md) | [0.15](/filings/0001811935-26-000054.md) |
| Basic EPS | $ per share | not reported | not reported | [0.09](/filings/0001811935-25-000057.md) | not reported | [0.17](/filings/0001811935-26-000039.md) | [0.18](/filings/0001811935-26-000054.md) | [(2.19)](/filings/0001811935-25-000057.md) | not reported | [0.17](/filings/0001811935-26-000039.md) | [0.16](/filings/0001811935-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [176](/filings/0001811935-26-000013.md) | not reported | not reported | [313](/filings/0001811935-25-000057.md) | [289](/filings/0001811935-26-000054.md) | [344](/filings/0001811935-26-000039.md) | [346](/filings/0001811935-26-000054.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [558](/filings/0001811935-26-000013.md) | not reported | not reported | [718](/filings/0001811935-25-000057.md) | [793](/filings/0001811935-26-000054.md) | [807](/filings/0001811935-26-000039.md) | [894](/filings/0001811935-26-000054.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [664](/filings/0001811935-26-000013.md) | not reported | not reported | [843](/filings/0001811935-25-000057.md) | [948](/filings/0001811935-26-000054.md) | [967](/filings/0001811935-26-000039.md) | [1,073](/filings/0001811935-26-000054.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [258](/filings/0001811935-26-000013.md) | not reported | not reported | [279](/filings/0001811935-25-000057.md) | [339](/filings/0001811935-26-000054.md) | [330](/filings/0001811935-26-000039.md) | [380](/filings/0001811935-26-000054.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [285](/filings/0001811935-26-000013.md) | not reported | not reported | [302](/filings/0001811935-25-000057.md) | [367](/filings/0001811935-26-000054.md) | [358](/filings/0001811935-26-000039.md) | [427](/filings/0001811935-26-000054.md) |
| Shareholders' equity | $m | [0.0](/filings/0001811935-26-000013.md) | [42.4](/filings/0001811935-26-000013.md) | [60.5](/filings/0001811935-25-000057.md) | [79.2](/filings/0001811935-25-000057.md) | [93.7](/filings/0001811935-25-000057.md) | [109](/filings/0001811935-26-000054.md) | [132](/filings/0001811935-26-000054.md) | [155](/filings/0001811935-26-000054.md) | [541](/filings/0001811935-25-000057.md) | [581](/filings/0001811935-26-000054.md) | [610](/filings/0001811935-26-000054.md) | [646](/filings/0001811935-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.5 d](/filings/0001811935-26-000013.md) | [48.4](/filings/0001811935-26-000039.md) | [2.0 d](/filings/0001811935-26-000054.md) | [40.5 d](/filings/0001811935-25-000057.md) | [8.5 d](/filings/0001811935-26-000013.md) | [72.6](/filings/0001811935-26-000039.md) | [14.7 d](/filings/0001811935-26-000054.md) |
| Capital expenditure | $m | [6.4 d](/filings/0001811935-26-000013.md) | [5.2](/filings/0001811935-26-000039.md) | [5.4 d](/filings/0001811935-26-000054.md) | [4.6 d](/filings/0001811935-25-000057.md) | [5.3 d](/filings/0001811935-26-000013.md) | [9.3](/filings/0001811935-26-000039.md) | [10.9 d](/filings/0001811935-26-000054.md) |
| Share repurchases | $m | not reported | [0.0](/filings/0001811935-26-000039.md) | [0.0 d](/filings/0001811935-26-000054.md) | not reported | not reported | [3.6](/filings/0001811935-26-000039.md) | [0.1 d](/filings/0001811935-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [90.8](/filings/0001811935-25-000057.md) | [90.6](/filings/0001811935-26-000039.md) | [90.6](/filings/0001811935-26-000054.md) | [102](/filings/0001811935-25-000057.md) | [179](/filings/0001811935-26-000039.md) | [181](/filings/0001811935-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.